Abstract
New potentially biologically active N-bromobenzyl derivatives of α-isosparteine and 2-methylsparteine were obtained. Newly obtained compounds were characterized by IR and NMR spectroscopy. The structure of the new compounds in solution was proposed
Keywords: Bromobenzyl derivatives, IR and NMR spectroscopy, sparteine derivatives, sparteine stereoisomers, antiinflammatory, antihypersensitive, antidepressant, antiarrhythmic, diuretic, hypoglicemic activity
Letters in Organic Chemistry
Title:Synthesis and Structure of New N-Bromobenzyl Bis-quinolizidine Derivatives
Volume: 9 Issue: 7
Author(s): Beata Jasiewicz, Karolina Malczewska-Jaskola and Katarzyna Polom
Affiliation:
Keywords: Bromobenzyl derivatives, IR and NMR spectroscopy, sparteine derivatives, sparteine stereoisomers, antiinflammatory, antihypersensitive, antidepressant, antiarrhythmic, diuretic, hypoglicemic activity
Abstract: New potentially biologically active N-bromobenzyl derivatives of α-isosparteine and 2-methylsparteine were obtained. Newly obtained compounds were characterized by IR and NMR spectroscopy. The structure of the new compounds in solution was proposed
Export Options
About this article
Cite this article as:
Jasiewicz Beata, Malczewska-Jaskola Karolina and Polom Katarzyna, Synthesis and Structure of New N-Bromobenzyl Bis-quinolizidine Derivatives, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139672
DOI https://dx.doi.org/10.2174/157017812802139672 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exercise and Cardiac Preconditioning Against Ischemia Reperfusion Injury
Current Cardiology Reviews Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
Current Pharmaceutical Design Nutritional Antioxidants and Their Applications in Cardiometabolic Diseases
Infectious Disorders - Drug Targets Exercise-Induced Modulation of Endothelial Nitric Oxide Production
Current Pharmaceutical Biotechnology Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Islet Purification for Clinical Islet Transplantation
Current Tissue Engineering (Discontinued) Coronary Calcium Risk Score and Cardiovascular Risk
Current Vascular Pharmacology Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [ Diseases of the Kidney: Molecular Mechanisms and Current Therapy Executive Editor: Stephen I-Hong Hsu ]
Current Molecular Medicine Safety of Vascular Endothelial and Hepatocyte Growth Factor Gene Therapy in Patients with Critical Limb Ischemia
Current Neurovascular Research Incretin-Based Therapies in Patients with Type 2 Diabetes
Current Drug Therapy The Pyruvate Dehydrogenase Complex as a Target for Gene Therapy
Current Gene Therapy Current Therapy in Sarcoidosis, the Role of Existing Drugs and Future Medicine
Inflammation & Allergy - Drug Targets (Discontinued) A Role for Endothelin-1 in Peripheral Vascular Disease
Current Vascular Pharmacology Nonalcoholic fatty liver disease in children and adolescents – Relationship with Polycystic Ovary Syndrome
Current Pharmaceutical Design Calcium Intake Requirements Along the Life Cycle and Associated Factors
Current Nutrition & Food Science Risk Factors for Development of Heart Failure
Current Cardiology Reviews Healing Effects of Curcumin Nanoparticles in Deep Tissue Injury Mouse Model
Current Drug Delivery Statin Treatment Non-adherence and Discontinuation: Clinical Implications and Potential Solutions
Current Pharmaceutical Design